Abiopharma

Novo Nordisk International Operations Commits to Veeva Vault CRM

Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism

Gain Therapeutics Announces Conference Participation During J.P. Morgan Healthcare Conference Week

Monte Rosa Therapeutics Announces Positive Interim Phase 1 Data of MRT-8102 Demonstrating Profound CRP Reductions in Elevated CVD-risk Subjects

Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week

Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones

Biohaven to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026

Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer

Liquidia Corporation to Present at 44th Annual J.P. Morgan Healthcare Conference

Avient To Hold Fourth Quarter 2025 Conference Call